Morphine or Fentanyl for Refractory Dyspnea in COPD
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COPD
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: Crossover, double blind, double dummy Randomized Controlled TrialMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: For both morphine retard capsules as fentanyl patches there is a placebo available. Participants will be treated in each period with both tablets and a patch. (morphine capsules+placebo patch, placebo capsules+fentanyl patch, placebo capsules+ placebo patch.)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03834363
- Collaborators
- Dutch Foundation for Asthma Prevention
- Innovatiefonds Zorgverzekeraars
- Investigators
- Principal Investigator: Huib AM Kerstjens, MD PhD University Medical Center Groningen